scholarly journals WHAM evidence summary: Use of yoghurt for managing malodorous wounds

WCET Journal ◽  
2021 ◽  
Vol 41 (4) ◽  
Author(s):  
Robin Watts ◽  
Terena Solomon
Keyword(s):  
Evidence Summary

scholarly journals Effectiveness of exercise therapy: A best-evidence summary of systematic reviews

2005 ◽  
Vol 51 (2) ◽  
pp. 71-85 ◽  
Author(s):  
Nynke Smidt ◽  
Henrica C.W. de Vet ◽  
Lex M. Bouter ◽  
Joost Dekker
Keyword(s):  
Exercise Therapy ◽  
Systematic Reviews ◽  
Evidence Summary

94 Short-term use of therapeutic opioids for children and future opioid use disorders: A systematic review and qualitative study of decision-maker information needs

2021 ◽  
Vol 26 (Supplement_1) ◽  
pp. e68-e68
Author(s):  
Malema Ahrari ◽  
Samina Ali ◽  
Michele Dyson ◽  
Lisa Hartling
Keyword(s):  
Systematic Review ◽  
Qualitative Study ◽  
Information Needs ◽  
Policy Decision ◽  
Decision Makers ◽  
Snowball Sampling ◽  
Opioid Use ◽  
Short Term ◽  
Short Term Exposure ◽  
Evidence Summary

Abstract Primary Subject area Emergency Medicine - Paediatric Background Healthcare visits, hospitalizations, and deaths due to opioid-related harms continue to rise for children, despite an overall decline in opioid prescriptions. Decision-makers (including patients and families, clinicians, and policy-makers) require high quality syntheses to inform decisions regarding opioid use. Previous research has found that how systematic review (SR) results are presented may influence uptake by decision-makers. Evidence summaries are appealing to decision-makers as they provide key messages in a succinct manner. Objectives 1) To conduct an SR examining the association between short-term therapeutic exposure to opioids in children and development of opioid use disorder, and 2) To gain perspectives from policy decision-makers on the usability and presentation of results through the form of an evidence summary. Design/Methods We conducted an SR following methods recommended by Cochrane. A medical librarian conducted a comprehensive search and two authors were involved in study selection, data extraction and quality assessment. Studies were eligible if they reported primary research in English or French, and study participants had therapeutic exposure to opioids before age 18 years. Results were described narratively. Decision makers were recruited through purposive and snowball sampling methods, and they participated in interviews to discuss an evidence summary based on the SR. Interviews were transcribed and data were analyzed using content analysis. Ethics approval was obtained for the qualitative study. Results Nineteen American studies involving 47,191,990 participants were included. One study demonstrated that short-term therapeutic exposure may be associated with opioid abuse. Four others showed an association without specifying duration of exposure. Fourteen studies provided information on prevalence or incidence of opioid misuse following therapeutic exposure, median 27.8% [interquartile range 21.4% – 30.7%]; notably, 12 of them did not specify duration of therapeutic exposure. Identified risk factors were contradictory and remain unclear. Decision makers had mixed preferences for the presentation of evidence, depending on their degree of involvement in research versus practice. A majority preferred having methods and key characteristics of studies included in the first page of the evidence summary. They noted that the summary should not be text-heavy and details should be appended. Conclusion A number of studies suggest there is an association between lifetime therapeutic opioid use (unknown duration) and future nonmedical opioid use; however, there is limited evidence to determine whether short-term exposure is specifically associated with these outcomes. Policy and decision-makers prefer a succinct evidence summary for this SR, with study-specific details provided as an appendix. PROSPERO Registration: 122681.

The treatment of lymphedema related to breast cancer: a systematic review and evidence summary

2004 ◽  
Vol 12 (6) ◽  
pp. 421-431 ◽  
Author(s):  
Lyn Kligman ◽  
Rebecca K. S. Wong ◽  
Mary Johnston ◽  
Nancy S. Laetsch
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Evidence Summary

scholarly journals COVID-19 Health Evidence Summary No.107

2021 ◽  
Author(s):  
Kerry Millington ◽  
Samantha Reddin
Keyword(s):  
Online Learning ◽  
Social Science ◽  
Prevention And Control ◽  
Clinical Characteristics ◽  
Infection Prevention ◽  
Decision Makers ◽  
Infection Prevention And Control ◽  
Evidence Summary ◽  
Indirect Impact ◽  
And Control

This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make original documents easily accessible to decision-makers which, if relevant to them, they should go to before making decisions. This summary covers publications on Clinical characteristics and management; Epidemiology and modelling; Infection Prevention and Control; Therapeutics; Vaccines; Indirect impact of COVID-19; Social Science; Comments, Editorials, Opinions, Blogs, News; Guidelines, Statements & Tools; Dashboards & Trackers; C19 Resource Hubs; and Online learning & events

scholarly journals Endocrine testing in obesity

2020 ◽  
Vol 182 (4) ◽  
pp. C13-C15 ◽  
Author(s):  
John P H Wilding
Keyword(s):  
Polycystic Ovarian Syndrome ◽  
Hormone Treatment ◽  
Endocrine Disorders ◽  
Metabolic Dysfunction ◽  
Testosterone Deficiency ◽  
Endocrine Dysfunction ◽  
Gonadal Dysfunction ◽  
Evidence Summary ◽  
Pituitary Adrenal Axis ◽  
Ovarian Syndrome

Endocrine disorders such as Cushing’s syndrome and hypothyroidism may cause weight gain and exacerbate metabolic dysfunction in obesity. Other forms of endocrine dysfunction, particularly gonadal dysfunction (predominantly testosterone deficiency in men and polycystic ovarian syndrome in women), and abnormalities of the hypothalamic-pituitary-adrenal axis, the growth hormone-IGF-1 system and vitamin D deficiency are common in obesity. As a result, endocrinologists may be referred people with obesity for endocrine testing and asked to consider treatment with various hormones. A recent systematic review and associated guidance from the European Society of Endocrinology provide a useful evidence summary and clear guidelines on endocrine testing and treatment in people with obesity. With the exception of screening for hypothyroidism, most endocrine testing is not recommended in the absence of clinical features of endocrine syndromes in obesity, and likewise hormone treatment is rarely needed. These guidelines should help reduce unnecessary endocrine testing in those referred for assessment of obesity and encourage clinicians to support patients with their attempts at weight loss, which if successful has a good chance of correcting any endocrine dysfunction.

scholarly journals Self-management programs for Aboriginal and Torres Strait Islander Peoples with chronic conditions: A rapid review

2017 ◽  
Vol 15 (2) ◽  
pp. 83-123
Author(s):  
Ellie Moore ◽  
Sharon Lawn ◽  
Candice Oster ◽  
Andrea Morello
Keyword(s):  
Chronic Condition ◽  
Torres Strait Islander ◽  
Grey Literature ◽  
Rapid Review ◽  
Self Management ◽  
Rigorous Evaluation ◽  
Cultural Appropriateness ◽  
Evidence Summary ◽  
Closing The Gap ◽  
Torres Strait

Objectives Review the evidence for the effectiveness of chronic condition self-management programs applied to Aboriginal and Torres Strait Islander Peoples. Methods A rapid review methodology was followed to develop an evidence summary from peer-reviewed and grey literature. Results Only seven peer-reviewed studies were identified. The evidence indicated that group programs, particularly the Stanford Program, and structured individual chronic condition self-management programs were of good quality for Aboriginal and Torres Strait Islander Peoples, although these need to be integrated into practice in order to see the greatest benefits. The Flinders Program showed promise as a standardised program with content designed specifically with and for these populations. Numerous grey literature sources were identified, many using strong participatory approaches developed locally within Aboriginal and Torres Strait Islander Peoples. However, few of these programs have been subject to rigorous evaluation. Discussion Despite the significant focus on chronic condition self-management programs to help address the burden of disease for Aboriginal and Torres Strait Islander Peoples, few studies exist that have been properly evaluated. The Closing the Gap Principles developed by the Australian Institute of Health and Welfare offer important guidance for how to proceed to maximise engagement, cultural appropriateness and ownership of program initiatives.

Sign in / Sign up

Export Citation Format

Share Document